Entourage Effect in Full Spectrum Products: What to Know
The entourage effect suggests cannabis compounds work together. Learn how full spectrum products preserve cannabinoids and terpenes, and how to evaluate them.
The entourage effect is the idea that compounds in cannabis act together. Cannabinoids such as THC and CBD, plus terpenes and flavonoids, may produce effects that no single compound produces alone. The term also covers a narrower claim: some compounds have weak or no activity on their own but change the potency of the compounds that do.
Entourage Effect in Full Spectrum Products: What to Know
Shimon Ben-Shoshan and Raphael Mechoulam used the phrase in a 1998 paper in the European Journal of Pharmacology. They studied fatty acid glycerol esters that did not bind cannabinoid receptors but extended and boosted the activity of 2-arachidonoyl-glycerol, an endocannabinoid.
Top Terpenes for the Entourage Effect in THC Products
Researchers later applied the phrase to whole-plant cannabis. Ethan Russo's 2011 review in the British Journal of Pharmacology argued that terpenes and minor cannabinoids modulate THC. That review is the source of most consumer-facing uses of the term.
Entourage Effect for Pain Relief: How Cannabinoids and Terpenes Work Together
Terpenes are the aromatic compounds that give each cultivar its smell. Common ones in cannabis include myrcene, limonene, linalool, alpha-pinene, beta-caryophyllene, terpinolene, and humulene. They appear at low percentages, often under 1% of flower weight by gas chromatography.
Most terpene claims come from cell and animal work, or from studies of essential oils. Labs differ in how they measure terpenes. Two labs can report different terpene numbers for the same flower because of sample handling, storage, and extraction methods.
Labels matter for this topic.
Products with added botanical terpenes are not the same as full-spectrum extracts. Those terpenes come from sources such as citrus and pine, not from the cannabis plant.
Clinical trials that test whole-plant cannabis against a single cannabinoid are few. A 2020 review in Cannabis and Cannabinoid Research argued that the term is overused and that data do not support whole-plant synergy for most endpoints. Other reviews reach similar conclusions.
Case reports and patient surveys describe better results from full-spectrum products than from isolates. These designs cannot control for expectation, dose, or route of use.
No standard exists for terpene ratios. No human dose-response curve has been published for any specific cannabinoid-terpene pair. The term describes a hypothesis, not a mechanism with clinical proof.